The Technical Analyst
Select Language :
Boiron SA [BOI.PA]

Exchange: EURONEXT Industry: Drug Manufacturers General Specialty & Generic

Boiron SA Price, Forecast, Insider, Ratings, Fundamentals & Signals

Boiron SA is listed at the  Exchange

-3.54% €34.10

America/New_York / 17 mai 2024 @ 11:35


FUNDAMENTALS
MarketCap: 592.05 mill
EPS: 2.06
P/E: 16.55
Earnings Date: May 20, 2024
SharesOutstanding: 17.36 mill
Avg Daily Volume: 0.0036 mill
RATING 2024-05-17
A
Buy
RATINGS
Rating CashFlow: Buy
Return On Equity: Strong Buy
Return On Asset: Strong Buy
DE: Sell
P/E: Buy
Price To Book: Neutral
QUARTER GROWTHS
1/222/223/224/222/234/23
Revenuen/an/an/an/a
Gr.Profitn/an/an/an/a
Ebitn/an/an/an/a
Asset n/an/an/an/a
Debtn/an/an/an/a
PE RATIO: COMPANY / SECTOR
0.94x
Company: PE 16.55 | sector: PE 17.68
PE RATIO: COMPANY / INDUSTRY
1.43x
Company: PE 16.55 | industry: PE 11.60
DISCOUNTED CASH FLOW VALUE
€32.60
(-4.40%) €-1.502
Date: 2024-05-19
Expected Trading Range (DAY)

€ 33.44 - 34.76

( +/- 1.92%)
ATR Model: 14 days

Live Trading Signals (every 1 min)

Forecast 1: 16:00 - €34.20
Forecast 2: 16:00 - €34.20
Forecast 3: 16:00 - €34.20
SCORE
10.00
Buy
Score Algorithm Version: 1.2C
Last version updated: Fri April 15th, 2022
Indicator Signals
RSI 21
SMA
Trend
Trend 2
Trend 3
MACD
Volume Signals
Price €34.10 (-3.54% )
Volume 0.0046 mill
Avg. Vol. 0.0036 mill
% of Avg. Vol 128.14 %
Signal 1:
Signal 2:

Today

Intraday chart data with high, low, open and close for Boiron SA

Last 12 Months

Last 12 months chart data with high, low, open and close for Boiron SA

RSI

Last 10 Buy & Sell Signals For BOI.PA

0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%

Avg return buy: 0.00 % | Avg return sell: 0.00 %

$1 invested is now $1.00 or 0.00% since Coming Soon

Date Signal @ Closed %
Profile picture for
            Boiron SA

BOI.PA

Boiron SA manufactures and sells homeopathic medicines in France, rest of Europe, North America, and internationally. The company offers non-proprietary, proprietary, branded homeopathic medicines. Its branded homeopathic medicines include Oscillococcinum to treat influenza symptoms, such as fever, chills, headaches, and aches; Stodal and Stodaline for treating coughs; Arnigel for adjunctive local treatment of benign trauma in the absence of open wounds; Camilia for the treatment of teething problems for babies; and Sédatif PC to treat anxiety and emotional, and minor sleep disorders. The company's homeopathic medicines also comprise Coryzalia for the treatment of cold symptoms and rhinitis; Homéoptic to treat eye discomfort and irritation due to various causes for adults and children; and Homéovox for vocal disorders. In addition, it provides dietary supplement; Dermoplasmine stick, baume, and mousse to treat dry lips and skin; Mag' Nuit, a formula to fall asleep; Arnitrosium for joint pain; Castor Equi Boiron ointment for treatment of cracked skin; and Storinyl, a syrup to treat colds. Further, it offers herbal medicines, such as Canephron to increase the amount of urine and to improve urinary elimination; moisturizing baby milk; and medical devices, including a range of COVID self-tests and rapid antigenic tests. The company offers its products through distribution centers, pharmacies, pharmacy chains, wholesalers, grocery and drugstores, health food stores, and online retail. Boiron SA was founded in 1932 and is headquartered in Messimy, France.

Last 10 Buy Signals

Date Signal @
SETHUSDMay 19 - 19:433 037.22
TKXUSDMay 19 - 19:5012.85
NXMUSDMay 19 - 19:5067.54
TOMOUSDMay 19 - 19:52$0.455
BSVUSDMay 19 - 19:51$64.80
SAKAIUSDMay 19 - 19:485.37
KASUSDMay 19 - 19:470.122
SNBNBUSDMay 19 - 19:43583.68
TONUSDMay 19 - 19:436.26
SCNSOLUSDMay 19 - 19:45204.33

Disclaimer:

"JimStromberg.com" is a research service that provides financial data and technical analysis of publicly traded stocks. All users should speak with their financial advisor before buying or selling any securities. Users should not base their investment decision upon "JimStromberg.com". By using the site you agree and are held liable for your own investment decisions and agree to Terms of Use and Privacy Policy. Please read the full disclaimer here.